Ars Medical sp. z o.o.

Piła, Wielkopolskie Województwo 64-920

0 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndromes

Studies at this site

• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling